Drug Trial Radar · NCT01082874
PeriOperative ISchemic Evaluation-2 Trial
Last checked: Nov 19, 2026Latest source record: Aug 25, 2016 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
10,010
Actual
Start
Jul 2010
Primary completion
Mar 2014
Study completion Jan 2015
Sponsor
- Lead sponsor
- Hamilton Health Sciences CorporationAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- McMaster University
- First posted
- Mar 9, 2010
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Factorial
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Prevention
- Who can join
- All sexes, from 45 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Major surgeries not involving the heart are common, and major heart problems during or after such surgeries represent a large population health problem. Few treatments to prevent heart problems around the time of surgery have been tested. There is encouraging data suggesting that small doses of Acetyl-Salicylic Acid (ASA) and Clonidine, which are two medications, given individually for a short period before and after major surgeries may prevent major heart problems. The POISE-2 Trial is a large international study to test if ASA and Clonidine can prevent heart attacks and deaths from heart problems around the time of surgery.
Conditions
- Cardiovascular Disease
Interventions
Active ClonidineDrug
Pre-op (goal 2-4 hours): 2 x 0.1mg oral tablets and transdermal patch (0.2 mg/day). Patch to be removed 72 hours post-op.
Placebo ClonidineDrug
Pre-op (goal 2-4 hours): 2 oral placebo tablets and transdermal placebo patch. Patch to be removed 72 hours post-op.
Active ASADrug
Pre-op (goal 2-4 hours): 2 x 100mg oral tablets. Post-op: patients ingest one tablet a day (100 mg ASA) for 7 days if patient was were taking ASA chronically prior to surgery or for 30 days if they were not chronically taking ASA prior to surgery
Placebo ASADrug
Pre-op (goal 2-4 hours): 2 oral placebo tablets. Post-op: patients ingest one placebo tablet a day for 7 days if patient was were taking ASA chronically prior to surgery or for 30 days if they were not chronically taking ASA prior to surgery
Primary outcomes
What the sponsor says the trial is designed to measure.
- Composite of All-cause Mortality and Nonfatal MITime frame: 30 days
- All-cause Mortality and Nonfatal MITime frame: 1 year
Locations
23 sites in 23 countries. Site status is shown where the registry gives one.
National Coordination Office
Cleveland, Ohio
National Coordination Office
Rosario, Argentina
National Coordination Office Australia and New Zealand
Parkville, Victoria, Australia
National Coordination Office
Vienna, Austria
National Coordination Office
Brussels, Belgium
National Coordination Office
São Paulo, Brazil
National Coordination Office
Hamilton, Ontario, Canada
National Coordination Office
Santiago, Chile
National Coordination Office
Bucamaranga, Colombia
National Coordination Office
Herlev, Denmark
National Coordination Office
Boulogne-Billancourt, France
National Coordination Office
Bonn, Germany
National Coordination Office
Hong Kong, Hong Kong
National Coordination Office
Bangalore, India
National Coordination Office
Milan, Italy
National Coordination Office
Kuala Lumpur, Malaysia
National Coordination Office
Auckland, New Zealand
National Coordination Office
Islamabad, Pakistan
National Coordination Office
Lima, Peru
National Coordination Office
Durban, South Africa
National Coordination Office
Barcelona, Spain
National Coordination Office
Basel, Switzerland
National Coordination Office
Hull, United Kingdom
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.